Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0001127602-23-020818

President and CEO sold 4,461 shares at an average $0.47 ($2,103)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-13 Sale : show line 1 in the form 10b5-1 −2,646 $0.39 $1,032 707,397 D
2023-07-14 Sale : show line 2 in the form 10b5-1 −1,815 $0.59 $1,071 705,582 D
Open-market sales · 4,461 sh · avg $0.47 · $2,103
Loading xslF345X05/form4.xml…